Denali Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000	Closed	-$34.4K	–	491
2023 Q1	$34.4K	Hold	2,000	–	–	0.01%	255
2022 Q4	$44.4K	Buy	+2,000	New	+$44.4K	0.02%	239